HTG Molecular Diagnostics (HTGM) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts HTGM Hot Sheet
Join SI Premium – FREE
HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q3 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.07 million.
For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Madrigal Pharma (MDGL) Tops Q2 EPS by 76c
- Brookfield Business Corporation (BBUC) Misses Q2 EPS by 124c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
